Get the Stockscreener App
114.81
2.20%
-2.58
After Hours:
114.81
Lemaitre Vascular Inc stock is traded at $114.81, with a volume of 115.33K.
It is down -2.20% in the last 24 hours and up +6.25% over the past month.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
See More
Previous Close:
$117.39
Open:
$117.02
24h Volume:
115.33K
Relative Volume:
0.54
Market Cap:
$2.62B
Revenue:
$249.60M
Net Income/Loss:
$57.73M
P/E Ratio:
45.67
EPS:
2.5139
Net Cash Flow:
$74.47M
1W Performance:
+2.14%
1M Performance:
+6.25%
6M Performance:
+31.57%
1Y Performance:
+35.66%
1-Day Range:
$114.09
$117.42
1-Week Range:
$110.66
$118.01
52-Week Range:
$78.01
$118.01
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
114.81 | 2.68B | 249.60M | 57.73M | 74.47M | 2.5139 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
LeMaitre Vascular (NASDAQ:LMAT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
Annex Advisory Services LLC Acquires 13,692 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026 - The Manila Times
LMAT | LeMaitre Vascular, Inc. FinancialsIncome Statement - Quiver Quantitative
LeMaitre Vascular, Inc. to Announce First Quarter 2026 Financial Results on May 5, 2026 - Quiver Quantitative
LeMaitre will post Q1 results after close, then hold a 5 p.m. call - Stock Titan
LeMaitre Vascular : Proxy Card for 2026 Annual Meeting - marketscreener.com
Lemaitre Vascular stock hits all-time high at 116.48 USD By Investing.com - Investing.com Australia
LeMaitre Vascular (NASDAQ:LMAT) Reaches New 1-Year HighWhat's Next? - MarketBeat
Lemaitre Vascular stock hits all-time high at 116.48 USD - Investing.com
LeMaitre Vascular (LMAT) details 2026 board, pay and auditor votes - Stock Titan
LeMaitre Vascular Announces Board Changes and Size Reduction - TipRanks
LeMaitre Vascular director Bridget Ross to step down after annual meeting - Investing.com India
Board reshuffle at LeMaitre Vascular (NASDAQ: LMAT) for 2026 vote - Stock Titan
Sell Signal: Is LeMaitre Vascular Inc a strong candidate for buy and holdMarket Sentiment Review & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Breakout Watch: Is LeMaitre Vascular Inc a top pick in the sector2026 Investor Takeaways & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Liquidity Mapping Around (LMAT) Price Events - Stock Traders Daily
Is LeMaitre Vascular, Inc. (LMAT) a good stock to buy now? - MSN
69,202 Shares in LeMaitre Vascular, Inc. $LMAT Acquired by Tudor Investment Corp ET AL - MarketBeat
LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference - Sahm
LeMaitre management to speak at Needham virtual healthcare conference - Stock Titan
New Strong Buy Stocks for November 14th - MSN
LMAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital - Defense World
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT - marketbeat.com
Gainers Report: Is LeMaitre Vascular Inc a strong candidate for buy and hold2026 EndofMonth & Weekly High Return Stock Forecasts - baoquankhu1.vn
LeMaitre Vascular, Inc. (LMAT): A bull case theory - MSN
Why (LMAT) Price Action Is Critical for Tactical Trading - Stock Traders Daily
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
LeMaitre (NASDAQ: LMAT) director receives dividend equivalent rights awards - Stock Titan
Dividend equivalents boost LeMaitre Vascular (LMAT) director stock awards - Stock Titan
LeMaitre Vascular (LMAT) director granted new dividend equivalent rights - Stock Titan
LeMaitre (NASDAQ: LMAT) director awarded new dividend equivalent rights - Stock Titan
LeMaitre (NASDAQ: LMAT) director awarded dividend equivalent rights - Stock Titan
LeMaitre Vascular (LMAT) president reports grants of dividend equivalent rights - Stock Titan
LeMaitre (LMAT) SVP awarded new dividend equivalent rights grants - stocktitan.net
LeMaitre Vascular (LMAT) CFO granted new dividend equivalent rights - stocktitan.net
LeMaitre Vascular (NASDAQ: LMAT) CEO receives dividend equivalent rights grants - Stock Titan
Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111 - Yahoo Finance
Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now? - Insider Monkey
JPMorgan Chase & Co. Has $10.68 Million Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
LeMaitre Vascular Executive Stock SaleMarch 2026 UpdateNews and Statistics - IndexBox
LeMaitre Vascular, Inc. (LMAT) Stock Forecasts - Yahoo! Finance Canada
LeMaitre Vascular Executive Stock Transaction Analysis - Intellectia AI
A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K - Yahoo Finance
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know - Yahoo Finance
LeMaitre Vascular Up 30% as Insider Sells $285K in Stock. Here's What Investors Should Know - The Motley Fool
Vanguard disaggregates holdings; LMAT ownership shown as 0% (Vanguard) - Stock Titan
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):